New Horizons in Type 1 Diabetes: FDA Approval of Lantidra and Emerging Therapies Published On 28 June 2024 In Biology Pharmacology R&D Regulatory Technologies The FDA has approved Lantidra, a groundbreaking donor-derived pancreatic islet cell therapy for type 1 diabetes, providi... By Editorial Staff
